Nuvectis Pharma, Inc. (NVCT)
NASDAQ·Healthcare·Biotechnology
$21.29
-7.43%
Mkt Cap $583.80M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (4 analysts)
$36.00
Range $33.00 – $39.00
Implied Upside
+69.1%
Consensus $36.00 vs current $21.29
NASDAQ·Healthcare·Biotechnology
$21.29
-7.43%
Mkt Cap $583.80M
Buy
3
Hold
0
Sell
0
Price Target (4 analysts)
$36.00
Range $33.00 – $39.00
+69.1%
Consensus $36.00 vs current $21.29